Protocol HKT-500-US10: A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Grade I or Grade II Ankle Sprain

Trial Profile

Protocol HKT-500-US10: A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Grade I or Grade II Ankle Sprain

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Ketoprofen (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Hisamitsu Pharmaceutical
  • Most Recent Events

    • 27 Apr 2010 Results have been announced, according to a Hisamitsu Pharmaceutical Co media release.
    • 09 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top